How to improve the diagnostic process
- PMID: 10631653
- DOI: 10.1007/BF03161082
How to improve the diagnostic process
Abstract
The existing therapeutic options for treating amyotrophic lateral sclerosis (ALS) are relatively limited but, as therapies improve, there will be a need for early diagnosis of this rare but fatal neurogenerative disorder. Early diagnosis not only requires the utility of a good biological marker, it also requires medical personnel who are experienced to consider/establish a diagnosis of ALS. In many countries, diagnosis of ALS follows a three-step process involving the family physician/practitioners, a community neurologist and an ALS specialist. This process is cumbersome and as the number of cases seen by the first two doctors is extremely small, their awareness is consequently low. There is an urgent need to improve the awareness of ALS in the family physicians but also within the general population. A number of elements which probably contribute to delays in achieving an early diagnosis of ALS will be discussed in this paper with the view of identifying how the diagnostic process can be improved.
Similar articles
-
An algorithm for ALS diagnosis and management.Neurology. 1999;53(8 Suppl 5):S58-62. Neurology. 1999. PMID: 10560641 Review.
-
Management of amyotrophic lateral sclerosis (ALS) by the family nurse practitioner: a timeline for anticipated referrals.J Am Acad Nurse Pract. 2011 Sep;23(9):464-72. doi: 10.1111/j.1745-7599.2011.00628.x. Epub 2011 Jun 15. J Am Acad Nurse Pract. 2011. PMID: 21899641 Review.
-
Integrating the algorithm into community practice.Neurology. 1999;53(8 Suppl 5):S63-6; discussion S67-71. Neurology. 1999. PMID: 10560642 Review.
-
The diagnostic process in ALS.J Neurol Sci. 1999 Jun;165 Suppl 1:S10-3. doi: 10.1016/s0022-510x(99)00020-9. J Neurol Sci. 1999. PMID: 10448975
-
ISIS Survey: an international study on the diagnostic process and its implications in amyotrophic lateral sclerosis.J Neurol. 1999 Nov;246 Suppl 3:III1-5. doi: 10.1007/BF03161081. J Neurol. 1999. PMID: 10631652
Cited by
-
Cost effectiveness of treatments for amyotrophic lateral sclerosis: a review of the literature.Pharmacoeconomics. 2002;20(6):367-87. doi: 10.2165/00019053-200220060-00002. Pharmacoeconomics. 2002. PMID: 12052096 Review.
-
Clinical characteristics of a large cohort of US participants enrolled in the National Amyotrophic Lateral Sclerosis (ALS) Registry, 2010-2015.Amyotroph Lateral Scler Frontotemporal Degener. 2019 Aug;20(5-6):413-420. doi: 10.1080/21678421.2019.1612435. Epub 2019 May 26. Amyotroph Lateral Scler Frontotemporal Degener. 2019. PMID: 31131638 Free PMC article.
-
Effect of neurofilament analysis on the diagnostic delay in amyotrophic lateral sclerosis.CNS Neurosci Ther. 2023 Jan;29(1):70-77. doi: 10.1111/cns.13960. Epub 2022 Sep 1. CNS Neurosci Ther. 2023. PMID: 36047371 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous